Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Table of Contents What Cagrilintide and Retatrutide Are and How They Work Approved Uses and Current Clinical Evidence in the UK How These Medicines May Affect Men Specifically Dosage, Administration, and What to Expect Side Effects, Risks, and Safety Considerations Availability on the NHS and Next Steps for Treatment Scientific References Frequently Asked Questions What Cagrilintide and Retatrutide Are and How They Work Cagrilintide is a long-acting amylin analogue that promotes satiety and slows gastric emptying, while retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and increase energy expenditure
licensed doctor reviews each patients health history, weight loss goals, and individual needs to determine whether treatment is appropriate and safe, so you can move forward with confidence
Note: The maintenance dose of 4.5 mg requires 135 units (1.35 mL), which exceeds a standard U100 insulin syringe capacity
Childhood obesity: public-health crisis, common sense cure
Here is my before and after pic
Rather than a one-size-fits-all approach, genetic insights allow your clinician to select the medication and starting dose most likely to succeed based on your biology
